These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31051278)

  • 21. Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients.
    Yunivita V; Dian S; Ganiem AR; Hayati E; Hanggono Achmad T; Purnama Dewi A; Teulen M; Meijerhof-Jager P; van Crevel R; Aarnoutse R; Ruslami R
    Int J Antimicrob Agents; 2016 Oct; 48(4):415-21. PubMed ID: 27526979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and Pharmacodynamics of Intensive Antituberculosis Treatment of Tuberculous Meningitis.
    Ding J; Thuy Thuong Thuong N; Pham TV; Heemskerk D; Pouplin T; Tran CTH; Nguyen MTH; Nguyen PH; Phan LP; Nguyen CVV; Thwaites G; Tarning J
    Clin Pharmacol Ther; 2020 Apr; 107(4):1023-1033. PubMed ID: 31956998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simultaneous population pharmacokinetic analysis of rifampicin in Malawian adults and children.
    Schipani A; Pertinez H; Mlota R; Molyneux E; Lopez N; Dzinjalamala FK; van Oosterhout JJ; Ward SA; Khoo S; Davies G
    Br J Clin Pharmacol; 2016 Apr; 81(4):679-87. PubMed ID: 26613187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical models to optimize treatment of tuberculous meningitis - A systematic review.
    Litjens CHC; Aarnoutse RE; Te Brake LHM
    Tuberculosis (Edinb); 2020 May; 122():101924. PubMed ID: 32501258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis.
    Abulfathi AA; Decloedt EH; Svensson EM; Diacon AH; Donald P; Reuter H
    Clin Pharmacokinet; 2019 Sep; 58(9):1103-1129. PubMed ID: 31049868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individualised dosing algorithm and personalised treatment of high-dose rifampicin for tuberculosis.
    Svensson RJ; Niward K; Davies Forsman L; Bruchfeld J; Paues J; Eliasson E; Schön T; Simonsson USH
    Br J Clin Pharmacol; 2019 Oct; 85(10):2341-2350. PubMed ID: 31269277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis.
    Jeena PM; Bishai WR; Pasipanodya JG; Gumbo T
    Antimicrob Agents Chemother; 2011 Feb; 55(2):539-45. PubMed ID: 21098246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting.
    Niward K; Davies Forsman L; Bruchfeld J; Chryssanthou E; Carlström O; Alomari T; Carlsson B; Pohanka A; Mansjö M; Jonsson Nordvall M; Johansson AG; Eliasson E; Werngren J; Paues J; Simonsson USH; Schön T
    J Antimicrob Chemother; 2018 Oct; 73(10):2838-2845. PubMed ID: 30124844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Passage of rifampicin into the cerebrospinal fluid in tuberculous meningitis].
    Woehrle R; Viallier J; Guerin JC; Bertoye A
    Lyon Med; 1972 May; 227(9):837-45. PubMed ID: 5075981
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of dried blood spot sampling for pharmacokinetic research and therapeutic drug monitoring of anti-tuberculosis drugs in children.
    Martial LC; Kerkhoff J; Martinez N; Rodríguez M; Coronel R; Molinas G; Roman M; Gomez R; Aguirre S; Jongedijk E; Huisman J; Touw DJ; Pérez D; Chaparro G; Gonzalez F; Aarnoutse RE; Alffenaar JW; Magis-Escurra C
    Int J Antimicrob Agents; 2018 Jul; 52(1):109-113. PubMed ID: 29751121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rifampin concentrations in cerebrospinal fluid of patients with tuberculous meningitis.
    Sippel JE; Mikhail IA; Girgis NI; Youssef HH
    Am Rev Respir Dis; 1974 May; 109(5):579-80. PubMed ID: 4823414
    [No Abstract]   [Full Text] [Related]  

  • 32. Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges.
    Nau R; Prange HW; Menck S; Kolenda H; Visser K; Seydel JK
    J Antimicrob Chemother; 1992 Jun; 29(6):719-24. PubMed ID: 1506352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacokinetics and pharmacodynamics of meropenem in the cerebrospinal fluid of neurosurgical patients.
    Tsumura R; Ikawa K; Morikawa N; Ikeda K; Shibukawa M; Iida K; Kurisu K
    J Chemother; 2008 Oct; 20(5):615-21. PubMed ID: 19028626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoroquinolones in the management of tuberculous meningitis: Systematic review and meta-analysis.
    Rizvi I; Malhotra HS; Garg RK; Kumar N; Uniyal R; Pandey S
    J Infect; 2018 Oct; 77(4):261-275. PubMed ID: 30017610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis.
    Alffenaar JW; van Altena R; Bökkerink HJ; Luijckx GJ; van Soolingen D; Aarnoutse RE; van der Werf TS
    Clin Infect Dis; 2009 Oct; 49(7):1080-2. PubMed ID: 19712035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rifampin breakpoint for Acinetobacter baumannii based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation.
    Lepe JA; García-Cabrera E; Gil-Navarro MV; Aznar J
    Rev Esp Quimioter; 2012 Jun; 25(2):134-8. PubMed ID: 22707102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis.
    López-Cortés LF; Ruiz-Valderas R; Viciana P; Alarcón-González A; Gómez-Mateos J; León-Jimenez E; Sarasanacenta M; López-Pua Y; Pachón J
    Clin Pharmacokinet; 2002; 41(9):681-90. PubMed ID: 12126459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics of rifampin in the treatment of Mycobacterium tuberculosis in Asian elephants.
    Egelund EF; Isaza R; Brock AP; Alsultan A; An G; Peloquin CA
    J Vet Pharmacol Ther; 2015 Apr; 38(2):137-43. PubMed ID: 25236765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population Pharmacokinetic Analysis of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children with Tuberculous Meningitis.
    Abdelgawad N; Tshavhungwe MP; Rohlwink U; McIlleron H; Abdelwahab MT; Wiesner L; Castel S; Steele C; Enslin JN; Thango NS; Denti P; Figaji A
    Antimicrob Agents Chemother; 2023 Mar; 67(3):e0147422. PubMed ID: 36815838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologically-Based Pharmacokinetic Modelling to Predict the Pharmacokinetics and Pharmacodynamics of Linezolid in Adults and Children with Tuberculous Meningitis.
    Litjens CHC; Verscheijden LFM; Svensson EM; van den Broek PHH; van Hove H; Koenderink JB; Russel FGM; Aarnoutse RE; Te Brake LHM
    Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.